← Back to All Filings

Sensus Healthcare President Buys $4.2k in SRTS Stock

Low SignificanceNovember 12, 2025 at 10:02:05 AM EST

Sensus Healthcare, Inc.

$SRTS4CIK: 0001494891

Subscribe to track SRTS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Sensus Healthcare President Buys $4.2k in SRTS Stock

Company: Sensus Healthcare, Inc. (SRTS) Form: 4 | Filed: 2025-11-12 Significance: Low

Insider: Sardano Michael Title: PRESIDENT AND GENERAL COUNSEL | Relationship: Director, Officer

Transaction: • Type: Buy • Shares: 1,000 • Price: $4.26 • Value: $4,260 • Owned After: 117,839

Key Insight: A minor open-market purchase by the company's President. The transaction size is not material relative to the company's market capitalization or the insider's total holdings.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Sensus Healthcare, Inc. (SRTS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The President and General Counsel of Sensus Healthcare made a small, routine open-market purchase of common stock valued at $4,260.
  • Market Impact: The transaction is too small to have a meaningful impact on the market.

Company Information

FieldValue
CompanySensus Healthcare, Inc.
Ticker SymbolSRTS
CIK0001494891
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameSardano Michael
CIK0001720602
Title/PositionPRESIDENT AND GENERAL COUNSEL
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-11
Transaction CodeP (Open Market Purchase)
Security TypeCommon Stock
Shares Involved1,000
Price Per Share$4.26
Total Value$4,260
Shares Owned After117,839
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,260
% of Market Cap0.006%
Shares Transacted1,000
% of Shares Outstanding0.006%
Post-Transaction Ownership117,839 shares (0.72% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Sensus Healthcare is a nano-cap company with a market capitalization of approximately $70 million. This $4,260 transaction is negligible in this context.
  • Ownership Concentration: The purchase slightly increases the insider's ownership to 0.72% of total shares outstanding, which is not a significant concentration.
  • Transaction Significance: The transaction represents less than 0.01% of both the company's market cap and its shares outstanding, categorizing it as having low significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: While insider buying is generally a positive signal, the extremely small size of this transaction makes it immaterial and unlikely to influence investor sentiment or stock price.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small to affect trading volume.
  • Sentiment Indicator: Neutral. The purchase is too minor to be considered a strong bullish signal.
Topics:#SECFiling#InsiderTrading#SRTS#SensusHealthcare#Form4#InsiderBuy#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.